The use of Goserelin in the management of endometriosis : review

J Moodley, S.R. Ramphal
In: Obstetrics and Gynaecology Forum · 2009 · vol. 19(1) , pp. 29–31 · W1552170195
Review OA: closed CC0 Metadata only
View on OpenAlex
⚙ AI-generated summary by qwen3.7-flash, 2026-10-04 ⓘ

This review examines the use of Goserelin, a GnRH agonist analogue administered via subcutaneous injection, in the management of endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Zoladex (Goserelin acetate implant) contains a synthetic decapeptide analogue of luteinising hormone releasing (GnRH) agonist analogue. Zoladex is designed for subcutaneous injection (sterile biodegradable product equivalent to 3.6mg Goserelin).

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK